PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21056473-1	2011	In this study we investigate the feasibility of generating self-adjuvanting vaccines capable of inducing high titre antibody responses following the covalent attachment of the TLR2 agonist Pam(2)Cys to intact proteins.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	189-198	toll-like receptor 2	Mus musculus	176-180	
15787968-3	2005	The structurally related lipopeptides with a head group lacking the fatty acyl residue at the amino-terminus (Pam(2)Cys) stimulate TLR2 and 6.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	110-119	toll-like receptor 2	Mus musculus	131-135	
32380167-4	2020	Novel oral vaccines consisting of a long tumour peptide and the TLR2 (Toll-like receptor 2) ligand Pam2Cys, formulated in either liposomes or W/O/W double emulsions, were developed.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	99-106	toll-like receptor 2	Mus musculus	64-68	
32380167-4	2020	Novel oral vaccines consisting of a long tumour peptide and the TLR2 (Toll-like receptor 2) ligand Pam2Cys, formulated in either liposomes or W/O/W double emulsions, were developed.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	99-106	toll-like receptor 2	Mus musculus	70-90	
30396012-5	2018	We show that administration of PEG-Pam2Cys, a soluble form of the TLR2 agonist S-[2,3-bis(palmitoyloxy)propyl] cysteine (Pam2Cys), significantly and dramatically reduces the numbers of malaria parasites that grow in the livers of mice following subsequent challenge with sporozoites.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	79-119	toll-like receptor 2	Mus musculus	66-70	
30396012-5	2018	We show that administration of PEG-Pam2Cys, a soluble form of the TLR2 agonist S-[2,3-bis(palmitoyloxy)propyl] cysteine (Pam2Cys), significantly and dramatically reduces the numbers of malaria parasites that grow in the livers of mice following subsequent challenge with sporozoites.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	35-42	toll-like receptor 2	Mus musculus	66-70	
31740096-2	2020	In the first, the Toll-like receptor 2 agonist Pam2Cys and the target antibody epitope are assembled as a module which is then coupled to a carrier protein as a source of antigens to stimulate T cell help.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	47-54	toll-like receptor 2	Mus musculus	18-38	
29575556-6	2018	To increase the affinity of the developed lipopeptides for the negatively charged plasma membrane, a cationic polypeptide was connected to Pam2Cys (P2C), which is the basic structure of the TLR2 ligand.	S-(2,3-bis(palmitoyloxy)propyl)cysteine	139-146	toll-like receptor 2	Mus musculus	190-194